Clinical Trials · NCT00557310
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 35
- Start date
- Nov 2007
- Locations
- 6 sites, United States, Canada
- Primary endpoint
- Percent Change From Baseline in Surface-to-Curve Ratio (SCR) in the Distal Radius at Month 18 Endpoint